Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Jackson

Showing results (31-40 of 182) with videos related to

Pageof 19
Sort By:
Annals of the American Thoracic Society|November 24, 2015
Pathogenesis of Viral Infection in Exacerbations of Airway DiseaseAndrew I Ritchie, Hugo A Farne, Aran Singanayagam, et al.
The Journal of Allergy and Clinical Immunology|October 9, 2017
Viral infections in allergy and immunology: How allergic inflammation influences viral infections and illnessMichael R Edwards, Katherine Strong, Aoife Cameron, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 11, 2022
Reply to "'Nothing about us without us' - What matters to patients with severe asthma?"John W Upham, Chantal Le Lievre, David J Jackson, et al.
BMJ Open Respiratory Research|September 29, 2021
Recommendations following a modified UK-Delphi consensus study on best practice for referral and management of severe asthmaDavid J Jackson, Claire Butler, Rekha Chaudhuri, et al.
The European Respiratory Journal|July 1, 2022
Benefits of specialist severe asthma management: demographic and geographic disparitiesCharlene Redmond, Liam G Heaney, Rekha Chaudhuri, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 16, 2021
Defining a Severe Asthma Super-Responder: Findings from a Delphi ProcessJohn W Upham, Chantal Le Lievre, David J Jackson, et al.
The Lancet. Respiratory Medicine|August 31, 2024
An international consensus on the use of asthma biologics in pregnancyJennifer Naftel, David J Jackson, Matthew Coleman, et al.
Frontiers in Allergy|March 23, 2026
Depemokimab demonstrates efficacy in patients with type 2 asthma with comorbid CRSwNP: Phase III SWIFT-1/-2 analysisEnrico Heffler, Diana Jarreta, Chang-Qing Zhu, et al.
Health Informatics Journal|August 4, 2025
ReferID<sup>+</sup> and AsthmaOptimiser: Digital tools to support structured asthma consultations in primary careDavid J Jackson, Hetal Dhruve, Bertine Flokstra-de Blok, et al.
Lancet (London, England)|April 24, 2022
Disease-modifying anti-asthmatic drugsMarek Lommatzsch, Guy G Brusselle, G Walter Canonica, et al.
Pageof 19

Showing results (31-40 of 182) with videos related to

Sort By:
Pageof 19
Annals of the American Thoracic Society|November 24, 2015
Pathogenesis of Viral Infection in Exacerbations of Airway DiseaseAndrew I Ritchie, Hugo A Farne, Aran Singanayagam, et al.
The Journal of Allergy and Clinical Immunology|October 9, 2017
Viral infections in allergy and immunology: How allergic inflammation influences viral infections and illnessMichael R Edwards, Katherine Strong, Aoife Cameron, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 11, 2022
Reply to "'Nothing about us without us' - What matters to patients with severe asthma?"John W Upham, Chantal Le Lievre, David J Jackson, et al.
BMJ Open Respiratory Research|September 29, 2021
Recommendations following a modified UK-Delphi consensus study on best practice for referral and management of severe asthmaDavid J Jackson, Claire Butler, Rekha Chaudhuri, et al.
The European Respiratory Journal|July 1, 2022
Benefits of specialist severe asthma management: demographic and geographic disparitiesCharlene Redmond, Liam G Heaney, Rekha Chaudhuri, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 16, 2021
Defining a Severe Asthma Super-Responder: Findings from a Delphi ProcessJohn W Upham, Chantal Le Lievre, David J Jackson, et al.
The Lancet. Respiratory Medicine|August 31, 2024
An international consensus on the use of asthma biologics in pregnancyJennifer Naftel, David J Jackson, Matthew Coleman, et al.
Frontiers in Allergy|March 23, 2026
Depemokimab demonstrates efficacy in patients with type 2 asthma with comorbid CRSwNP: Phase III SWIFT-1/-2 analysisEnrico Heffler, Diana Jarreta, Chang-Qing Zhu, et al.
Health Informatics Journal|August 4, 2025
ReferID<sup>+</sup> and AsthmaOptimiser: Digital tools to support structured asthma consultations in primary careDavid J Jackson, Hetal Dhruve, Bertine Flokstra-de Blok, et al.
Lancet (London, England)|April 24, 2022
Disease-modifying anti-asthmatic drugsMarek Lommatzsch, Guy G Brusselle, G Walter Canonica, et al.
Pageof 19